Concepedia

Tomáš Reischig

TR

Statistics

Publications

29

Citations

1.2K

H-Index

21

Active since

2002

Affiliations

Charles University(Current)

University Hospital Plzen

Institute of Clinical and Experimental Medicine

Université Libre de Bruxelles

Metabolism and Renal Physiology

Tomáš Reischig is an author at Charles University specializing in immunosuppression in kidney transplantation, kidney transplantation, and medicine.

ORCID

Publications per year

2002–2023

29

Publications

29

Valacyclovir Prophylaxis Versus Preemptive Valganciclovir Therapy to Prevent Cytomegalovirus Disease After Renal Transplantation

Tomáš Reischig, Pavel Jindra, Ondřej Hes et al. · American Journal of Transplantation · 2007 · 218 citations · Full text

, , +15

The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection

Tomáš Reischig, Pavel Jindra, Miroslava Švecová et al. · Journal of Clinical Virology · 2006 · 87 citations

, , +16

Effect of Cytomegalovirus Viremia on Subclinical Rejection or Interstitial Fibrosis and Tubular Atrophy in Protocol Biopsy at 3 Months in Renal Allograft Recipients Managed by Preemptive Therapy or Antiviral Prophylaxis

Tomáš Reischig, Pavel Jindra, Ondřej Hes et al. · Transplantation · 2009 · 79 citations

, , +17

Long-Term Outcomes of Pre-emptive Valganciclovir Compared with Valacyclovir Prophylaxis for Prevention of Cytomegalovirus in Renal Transplantation

Tomáš Reischig, Petra Hřibová, Pavel Jindra et al. · Journal of the American Society of Nephrology · 2012 · 75 citations · Full text

, , +16

Valacyclovir for Cytomegalovirus Prophylaxis Reduces the Risk of Acute Renal Allograft Rejection

Tomáš Reischig, Pavel Jindra, J Mareš et al. · Transplantation · 2005 · 73 citations

, , +17

1–5 of 29